Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.57 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.57 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | PBRM1 | Q86U86 | 2/20 | 0.49 |
| ▸ | HAVCR2 | Q8TDQ0 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6915204 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6909416 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6915995 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6913041 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6915043 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6909419 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6913045 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6915652 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6912784 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 | |
| SCHEMBL6915042 | 0.98 | TSHR (0.61) | TSHRALDH1A1NR4A2NR4A1NR4A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115954444-B | Preparation method of naphthalene polycarboxylate organic material and application of naphthalene polycarboxylate organic material in metal ion battery | 中国科学院深圳先进技术研究院 | 2025-01-14 | — | — | CN | disclosed |
| WO-2023277630-A1 | GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR | 주식회사 티움바이오 | 2023-01-05 | — | — | WO | disclosed |
| US-9447054-B2 | Anticancer supplement agent including benzo[D]oxazol derivative as effective ingredient | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES (KR) | 2016-09-20 | — | — | US | disclosed |
| US-9447054-B2 | Anticancer supplement agent including benzo[D]oxazol derivative as effective ingredient | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES (KR) | 2016-09-20 | — | — | US | disclosed |
| US-9447054-B2 | Anticancer supplement agent including benzo[D]oxazol derivative as effective ingredient | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES (KR) | 2016-09-20 | — | — | US | disclosed |
| US-20150197498-A1 | ANTICANCER SUPPLEMENT AGENT INCLUDING BENZO[D]OXAZOL DERIVATIVE AS EFFECTIVE INGREDIENT | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES (KR) | 2015-07-16 | — | — | US | disclosed |
| US-20150197498-A1 | ANTICANCER SUPPLEMENT AGENT INCLUDING BENZO[D]OXAZOL DERIVATIVE AS EFFECTIVE INGREDIENT | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES (KR) | 2015-07-16 | — | — | US | disclosed |
| US-20150197498-A1 | ANTICANCER SUPPLEMENT AGENT INCLUDING BENZO[D]OXAZOL DERIVATIVE AS EFFECTIVE INGREDIENT | KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES (KR) | 2015-07-16 | — | — | US | disclosed |
| US-20150150852-A1 | TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | SIGA TECHNOLOGIES, INC. (US) | 2015-06-04 | — | — | US | disclosed |
| US-8993604-B2 | Treatment and prevention of dengue virus infections | SIGA TECHNOLOGIES, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| CN-101155817-A | Dihydroimidazothiazole derivatives | PROSIDION LTD (GB) | 2008-04-02 | — | — | CN | disclosed |
| EP-1851232-A2 | DIHYDROIMIDAZOTHIAZOLE DERIVATIVES | Prosidion Limited (GB) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006085118-A2 | DIHYDROIMIDAZOTHIAZOLE DERIVATIVES | PROSIDION LIMITED (GB) | 2006-08-17 | — | — | WO | disclosed |
| US-20060128823-A1 | Radiation curable inkjet recording ink, and method of producing planographic printing plate using same, and ink composition, inkjet recording method, printed material, method of producing a planographic printing plate, and planographic printing plate | FUJI PHOTO FILM CO., LTD. | 2006-06-15 | — | — | US | disclosed |
| EP-1657286-A2 | Radiation curable ink jet ink, comprising a polymerisation initiation sensitising dye | FUJI PHOTO FILM CO., LTD. (JP) | 2006-05-17 | — | — | EP | disclosed |
| US-6982348-B2 | Aminoethanol derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-01-03 | — | — | US | disclosed |
| US-20040127574-A1 | Aminoethanol derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-07-01 | — | — | US | disclosed |
| EP-1362846-A1 | AMINOETHANOL DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-4224225-A | PHOTOPOLYMERIZATION INITIATOR | FUJI PHOTO FILM CO., LTD. (JP) | 1980-09-23 | — | — | US | disclosed |
| US-4036838-A | Process for the production of nitro derivatives of aromatic compounds | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150150852-A1 | TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | HAVCR2, TTPA, CHIA | TSHR 3237/4885ALDH1A1 899/4885NR4A2 611/4885 |
| US-20040127574-A1 | Aminoethanol derivatives | CETP, LCAT, MTTP | TSHR 3729/4885ALDH1A1 783/4885NR4A2 649/4885 |
| US-20150197498-A1 | ANTICANCER SUPPLEMENT AGENT INCLUDING BENZO[D]OXAZOL DERIVATIVE AS EFFECTIVE INGREDIENT | NFE2L2, KEAP1, OXA1L | TSHR 4516/4885ALDH1A1 425/4885NR4A2 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.